Avant Diagnostics, Inc. has commenced calibration testing of OvaDx®, a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to ovarian tumor cell development. In a recent news release, the company indicated that it expects to complete this calibration testing later this month, allowing it to move forward […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.